Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) EPS (Basic): 2010-2024

Historic EPS (Basic) for Sunshine Biopharma (SBFM) over the last 13 years, with Dec 2024 value amounting to -$7.32.

  • Sunshine Biopharma's EPS (Basic) rose 79.79% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.27, marking a year-over-year increase of 105.35%. This contributed to the annual value of -$7.32 for FY2024, which is 97.92% up from last year.
  • As of FY2024, Sunshine Biopharma's EPS (Basic) stood at -$7.32, which was up 97.92% from -$351.36 recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's EPS (Basic) ranged from a high of -$2.73 in FY2020 and a low of -$2,368 during FY2022.
  • For the 3-year period, Sunshine Biopharma's EPS (Basic) averaged around -$908.97, with its median value being -$351.36 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 49,652.77% in 2022, then surged by 97.92% in 2024.
  • Sunshine Biopharma's EPS (Basic) (Yearly) stood at -$2.73 in 2020, then crashed by 74.36% to -$4.76 in 2021, then tumbled by 49,652.77% to -$2,368 in 2022, then skyrocketed by 85.16% to -$351.36 in 2023, then skyrocketed by 97.92% to -$7.32 in 2024.